Unique Ethical Issues In Phase I Oncology Studies

By Luke Gelinas, PhD, IRB Chairperson at Advarra and Dan Kronish, MD, IRB Chairperson at Advarra

Oncology research represents a significant percentage of all clinical research, reflecting the fact that cancer continues to be a leading cause of mortality and morbidity worldwide. At the same time, significant treatment advances for different types of cancers in the past decade have been made, and the death rate from cancer is declining in the United States. Learn how Phase I oncology trials play an essential role in assessing investigational therapeutic safety and determining whether they are promising candidates for further exploration. 

To learn more about Advarra, visit their Clinical Leader page.